I am writing a series on the results of our Lester’s Oil human trial. As I’ve said before, there are thousands of supplements sold in New Zealand—and you can probably count those with real research behind them on the fingers of one hand.
I’ll keep these articles briefer than some of my former 22-volume Odysseys ????, and in this week’s issue I’ll focus on HDL cholesterol.
HDL cholesterol is often referred to as the “good” cholesterol. In short, cholesterol may become a concern when smaller particles of LDL (commonly known as “bad” cholesterol) accumulate where they don’t belong. Many researchers now believe that certain lifestyle factors may influence the way the body responds to these particles over time.
The standard approach your GP may suggest often includes pharmaceutical intervention. However, we encourage people to have informed conversations with their healthcare providers, especially as perspectives around cholesterol continue to evolve.
HDL cholesterol plays a key role in supporting a healthy cholesterol balance. It travels through the bloodstream and helps clear LDL cholesterol from areas where it may not be beneficial. HDL also plays a role in maintaining the health of blood vessel walls.
Even elevated LDL cholesterol may not always be a major concern on its own—it’s often the broader picture that matters, including factors such as dietary habits, inactivity, excess sugar and alcohol intake, and an imbalance between Omega-6 and Omega-3 intake. Omega-3, such as that found in fish oil, supports a healthy inflammatory response.
Lester’s Oil is a well-rounded supplement that may help support these important functions. In a human trial conducted by the Nutragenomics Research Group at the University of Auckland, our product was observed to support healthy HDL cholesterol levels over a short period. It’s one of the few supplements on the market that has been studied directly as a finished formula.
You can feel confident knowing that Lester’s Oil isn’t just backed by generic ingredient research—it’s been tested in its full form, and the early results are promising.
